Cizzle Biotechnology Holdings PLC (CIZ) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.199x

Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) has a cash flow conversion efficiency ratio of 1.199x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-331.00K ≈ $-40.27 USD) by net assets (GBX-276.00K ≈ $-33.58 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Cizzle Biotechnology Holdings PLC to measure how much of total assets are equity-financed.

Cizzle Biotechnology Holdings PLC - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Cizzle Biotechnology Holdings PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Cizzle Biotechnology Holdings PLC to evaluate the quality of earnings relative to operating cash generation.

Cizzle Biotechnology Holdings PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cizzle Biotechnology Holdings PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ECR Minerals plc LSE:ECR	0.041x
Comptoir Group PLC LSE:COM	11.244x
Mercantile Ports & Logistics Ltd LSE:MPL	-0.010x
Touchstar plc LSE:TST	-0.136x
Abacus Global Management, Inc. NASDAQ:ABX	-0.075x
Landore Resources Plc LSE:LND	-1.772x
Tower Resources plc LSE:TRP	0.068x
Northamber PLC LSE:NAR	0.110x

Annual Cash Flow Conversion Efficiency for Cizzle Biotechnology Holdings PLC (2006–2024)

The table below shows the annual cash flow conversion efficiency of Cizzle Biotechnology Holdings PLC from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Cizzle Biotechnology Holdings PLC (CIZ) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX82.00K ≈ $9.98	GBX-358.00K ≈ $-43.56	-4.366x	-929.63%
2023-12-31	GBX1.51 Million ≈ $183.36	GBX-639.00K ≈ $-77.75	-0.424x	-28.37%
2022-12-31	GBX2.64 Million ≈ $321.21	GBX-872.00K ≈ $-106.10	-0.330x	+69.33%
2021-12-31	GBX937.00K ≈ $114.01	GBX-1.01 Million ≈ $-122.77	-1.077x	+88.28%
2020-12-31	GBX32.00K ≈ $3.89	GBX-294.00K ≈ $-35.77	-9.188x	-761.46%
2019-12-31	GBX6.63K ≈ $0.81	GBX-7.07K ≈ $-0.86	-1.067x	-148.86%
2018-12-31	GBX-235.00K ≈ $-28.59	GBX-513.00K ≈ $-62.42	2.183x	+951.36%
2017-12-31	GBX741.00K ≈ $90.16	GBX-190.00K ≈ $-23.12	-0.256x	-401.49%
2016-12-31	GBX2.19 Million ≈ $266.09	GBX186.00K ≈ $22.63	0.085x	+135.88%
2015-12-31	GBX2.40 Million ≈ $292.62	GBX-570.00K ≈ $-69.35	-0.237x	-127.41%
2014-12-31	GBX5.05 Million ≈ $614.07	GBX-526.00K ≈ $-64.00	-0.104x	+34.38%
2013-12-31	GBX4.27 Million ≈ $519.41	GBX-678.00K ≈ $-82.49	-0.159x	-424.98%
2012-12-31	GBX4.79 Million ≈ $583.17	GBX-145.00K ≈ $-17.64	-0.030x	+91.82%
2011-12-31	GBX4.08 Million ≈ $496.90	GBX-1.51 Million ≈ $-183.72	-0.370x	-329.38%
2010-12-31	GBX3.54 Million ≈ $430.96	GBX-305.00K ≈ $-37.11	-0.086x	+70.09%
2009-12-31	GBX521.00K ≈ $63.39	GBX-150.00K ≈ $-18.25	-0.288x	+69.03%
2008-12-31	GBX1.67 Million ≈ $202.70	GBX-1.55 Million ≈ $-188.47	-0.930x	-6.47%
2007-12-31	GBX2.40 Million ≈ $291.89	GBX-2.10 Million ≈ $-254.90	-0.873x	-104.62%
2006-12-31	GBX-58.00K ≈ $-7.06	GBX-1.10 Million ≈ $-133.47	18.914x	--

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$81.99K

GBX673.87 Million GBX

Market Cap Rank

#31413 Global

#1143 in UK

Share Price

GBX1.70

Change (1 day)

-2.86%

52-Week Range

GBX1.29 - GBX3.65

All Time High

GBX1144.91